Bezafibrate
Overview
Bezafibrate is anti-hyperlipidimic agent. Bezafibrate is used to reduce high blood fats and cholesterol levels.
Primary Characterstics
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
The symptomatic adverse reactions produced by Bezafibrate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, GI distention, Myositic syndrome.
Back to top
Dosage
Triptorelin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 200 mg | 200 (200) | 8 hourly | PO | With or after food. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Triptorelin is available. |
Neonatal Dosage (3kg)
|
| | | | Not recommended in this age group |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Triptorelin
Back to top
Previous Drug Generic - Next Drug Generic